APA (7th ed.) Citation

Lin, A., Wei, T., Meng, H., Luo, P., & Zhang, J. (2019). Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations. Molecular Cancer, 18(1), N.PAG. https://doi.org/10.1186/s12943-019-1062-7

Chicago Style (17th ed.) Citation

Lin, Anqi, Ting Wei, Hui Meng, Peng Luo, and Jian Zhang. "Role of the Dynamic Tumor Microenvironment in Controversies Regarding Immune Checkpoint Inhibitors for the Treatment of Non-small Cell Lung Cancer (NSCLC) with EGFR Mutations." Molecular Cancer 18, no. 1 (2019): N.PAG. https://doi.org/10.1186/s12943-019-1062-7.

MLA (9th ed.) Citation

Lin, Anqi, et al. "Role of the Dynamic Tumor Microenvironment in Controversies Regarding Immune Checkpoint Inhibitors for the Treatment of Non-small Cell Lung Cancer (NSCLC) with EGFR Mutations." Molecular Cancer, vol. 18, no. 1, 2019, p. N.PAG, https://doi.org/10.1186/s12943-019-1062-7.